Literature DB >> 29552233

Cyclic Strain and Hypertension Increase Osteopontin Expression in the Aorta.

Christa Caesar1,2, Alicia N Lyle1, Giji Joseph1, Daiana Weiss1, Fadi M F Alameddine1, Bernard Lassègue1, Kathy K Griendling1, W Robert Taylor1,2,3.   

Abstract

Hypertension has a direct impact on vascular hypertrophy and is a known risk factor for the development of atherosclerosis. Osteopontin (OPN) has emerged as an important protein mediator of inflammation and remodeling of large arteries. However, its role and mechanism of regulation in the setting of hypertension is still unknown. Our objectives for this study were therefore to investigate the role of OPN in hypertension-induced vascular remodeling and inflammation. OPN Knockout (KO) and wild type (WT) mice were made hypertensive with angiotensin II (Ang II) infusion for seven days. We observed that OPN KO aortas were protected against Ang II-induced medial hypertrophy and inflammation, despite comparable increases in systolic blood pressure (SBP) in both groups. OPN expression was increased in WT aortas from hypertensive mice (induced by either Ang II or norepinephrine). OPN expression was increased in aortic smooth muscle cells (SMCs) subjected to cyclic mechanical strain suggesting that mechanical deformation of the aortic wall is responsible in part for the increased OPN expression induced by hypertension. Finally, we utilized hypertensive transgenic smooth muscle cell-specific catalase overexpressing (TgSMC-Cat) mice to determine the role of H2O2 in mediating hypertension-induced increases in OPN expression. We also found that the hypertension-induced increase in OPN expression was inhibited in transgenic smooth muscle cell-specific catalase overexpressing (TgSMC-Cat) mice, suggesting that H2O2, plays a vital role in mediating the hypertension-induced increase in OPN expression. Taken together, these results define a potentially important role for OPN in the pathophysiology of hypertension.

Entities:  

Keywords:  Angiotensin II; Cyclic strain; Inflammation; Norepinephrine; Smooth muscle cells; Vascular hypertrophy

Year:  2016        PMID: 29552233      PMCID: PMC5851655          DOI: 10.1007/s12195-016-0475-2

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  41 in total

1.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Authors:  T Wada; M D McKee; S Steitz; C M Giachelli
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

3.  Osteopontin and carotid atherosclerosis in patients with essential hypertension.

Authors:  Mie Kurata; Takafumi Okura; Sanae Watanabe; Tomikazu Fukuoka; Jitsuo Higaki
Journal:  Clin Sci (Lond)       Date:  2006-11       Impact factor: 6.124

4.  Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms.

Authors:  Ioannis Parastatidis; Daiana Weiss; Giji Joseph; W Robert Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-15       Impact factor: 8.311

5.  Development of atherosclerosis in osteopontin transgenic mice.

Authors:  Satoru Chiba; Hiroshi Okamoto; Shigeyuki Kon; Chiemi Kimura; Masaaki Murakami; Manabu Inobe; Yutaka Matsui; Takeshi Sugawara; Toshihiro Shimizu; Toshimitsu Uede; Akira Kitabatake
Journal:  Heart Vessels       Date:  2002-03       Impact factor: 2.037

6.  Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II.

Authors:  Daiana Weiss; W Robert Taylor
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

7.  Mechanical pressure versus intrinsic effects of hypertension on large arteries in humans.

Authors:  R Armentano; A Simon; J Levenson; N P Chau; J L Megnien; R Pichel
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

8.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

9.  Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

Authors:  D E Vaughan; S A Lazos; K Tong
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Longitudinal and circumferential strain of the proximal aorta.

Authors:  Vanessa Bell; William A Mitchell; Sigurður Sigurðsson; Jos J M Westenberg; John D Gotal; Alyssa A Torjesen; Thor Aspelund; Lenore J Launer; Albert de Roos; Vilmundur Gudnason; Tamara B Harris; Gary F Mitchell
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

View more
  5 in total

1.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

2.  The cofilin phosphatase slingshot homolog 1 restrains angiotensin II-induced vascular hypertrophy and fibrosis in vivo.

Authors:  Holly C Williams; Jing Ma; Daiana Weiss; Bernard Lassègue; Roy L Sutliff; Alejandra San Martín
Journal:  Lab Invest       Date:  2018-10-05       Impact factor: 5.662

3.  Cerebrovascular damage after midlife transient hypertension in non-transgenic and Alzheimer's disease rats.

Authors:  Aaron Y Lai; Illsung L Joo; Arunachala U Trivedi; Adrienne Dorr; Mary E Hill; Bojana Stefanovic; JoAnne McLaurin
Journal:  Brain Res       Date:  2021-02-12       Impact factor: 3.252

4.  Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness.

Authors:  Amra Jujić; Peter M Nilsson; Naeimeh Atabaki-Pasdar; Anna Dieden; Tiinamaija Tuomi; Paul W Franks; Jens Juul Holst; Signe Sørensen Torekov; Susana Ravassa; Javier Díez; Margaretha Persson; Emma Ahlqvist; Olle Melander; Maria F Gomez; Leif Groop; Martin Magnusson
Journal:  Diabetes Care       Date:  2020-11-18       Impact factor: 19.112

Review 5.  Rare Causes of Arterial Hypertension and Thoracic Aortic Aneurysms-A Case-Based Review.

Authors:  Svetlana Encica; Adrian Molnar; Simona Manole; Teodora Filan; Simona Oprița; Eugen Bursașiu; Romana Vulturar; Laura Damian
Journal:  Diagnostics (Basel)       Date:  2021-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.